Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study

Lene Dreyer; René Lindholm Cordtz; Inger Marie J. Hansen; Lars Erik Kristensen; Merete Lund Hetland; Lene Mellemkjær

Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study

Lene Dreyer, René Lindholm Cordtz, Inger Marie J. Hansen, Lars Erik Kristensen, Merete Lund Hetland, Lene Mellemkjær

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatology
Vol/bind	69
Udgave nummer	S10
ISSN	2326-5205
Status	Udgivet - 2017
Udgivet eksternt	Ja
Begivenhed	The American College of Rheumatology, ACR/ARHP Annual meeting 2017 - San Diego, USA Varighed: 3 nov. 2017 → 8 nov. 2017 http://acrabstracts.org/ https://www.rheumatology.org/Annual-Meeting

Konference

Konference	The American College of Rheumatology, ACR/ARHP Annual meeting 2017
Land/Område	USA
By	San Diego
Periode	03/11/2017 → 08/11/2017
Internetadresse	http://acrabstracts.org/ https://www.rheumatology.org/Annual-Meeting

Bibliografisk note

Abstract no. 11L

Adgang til dokumentet

https://acrabstracts.org/abstract/risk-of-second-malignant-neoplasm-and-mortality-in-rheumatoid-arthritis-patients-treated-with-biological-dmards-a-danish-population-based-cohort-study/

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Dreyer, L., Cordtz, R. L., Hansen, I. M. J., Kristensen, L. E., Hetland, M. L., & Mellemkjær, L. (2017). Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study. Arthritis & Rheumatology, 69(S10). https://acrabstracts.org/abstract/risk-of-second-malignant-neoplasm-and-mortality-in-rheumatoid-arthritis-patients-treated-with-biological-dmards-a-danish-population-based-cohort-study/

@article{2b6cd62b15cc4f83816419e7d47bf753,

title = "Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study",

author = "Lene Dreyer and Cordtz, {Ren{\'e} Lindholm} and Hansen, {Inger Marie J.} and Kristensen, {Lars Erik} and Hetland, {Merete Lund} and Lene Mellemkj{\ae}r",

note = "Abstract no. 11L; The American College of Rheumatology, ACR/ARHP Annual meeting 2017 ; Conference date: 03-11-2017 Through 08-11-2017",

year = "2017",

language = "English",

volume = "69",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "S10",

url = "http://acrabstracts.org/, https://www.rheumatology.org/Annual-Meeting",

}

Dreyer, L, Cordtz, RL, Hansen, IMJ, Kristensen, LE, Hetland, ML & Mellemkjær, L 2017, 'Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study', Arthritis & Rheumatology, bind 69, nr. S10. <https://acrabstracts.org/abstract/risk-of-second-malignant-neoplasm-and-mortality-in-rheumatoid-arthritis-patients-treated-with-biological-dmards-a-danish-population-based-cohort-study/>

Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study. / Dreyer, Lene; Cordtz, René Lindholm; Hansen, Inger Marie J. et al.
I: Arthritis & Rheumatology, Bind 69, Nr. S10, 2017.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards

T2 - The American College of Rheumatology, ACR/ARHP Annual meeting 2017

AU - Dreyer, Lene

AU - Cordtz, René Lindholm

AU - Hansen, Inger Marie J.

AU - Kristensen, Lars Erik

AU - Hetland, Merete Lund

AU - Mellemkjær, Lene

N1 - Abstract no. 11L

PY - 2017

Y1 - 2017

M3 - Conference abstract in journal

SN - 2326-5205

VL - 69

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - S10

Y2 - 3 November 2017 through 8 November 2017

ER -